Colistin as A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter baumannii In vivo and In vitro
Acinetobacter baumannii (A. baumannii) is a major opportunistic nosocomial pathogen, mostly resistant to several groups of antibiotics. Colistin is now used as a last-line treatment for isolates that are highly resistant. The purpose of this study is to identify the importance of LptD; whi...
Saved in:
| Main Authors: | Halah H. Al-Haideri, Nagham Saad Mohammed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Baghdad, College of Science for Women
2022-04-01
|
| Series: | مجلة بغداد للعلوم |
| Subjects: | |
| Online Access: | https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/5706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY OF COLISTIN AND CEFIDEROCOL ON CARBAPENEM RESISTANT Acinetobacter baumannii ISOLATES
by: Feyza Balci, et al.
Published: (2024-12-01) -
Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
by: Suyeon Park, et al.
Published: (2025-02-01) -
Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
by: Abhishek Nandy, et al.
Published: (2022-11-01) -
Genotyping of carbapenem resistant Acinetobacter baumannii isolated from Egyptian patients
by: Heba Ahmed Mohamed, et al.
Published: (2022-12-01) -
Correction: Phage derived lytic peptides, a secret weapon against Acinetobacter baumannii—An in silico approach
by: Abhishek Nandy, et al.
Published: (2025-06-01)